| Dr Leslie Catherine Taguba-madrid, MD | |
|
1163 Route 37 W, Suite A-1, Toms River, NJ 08755-4973 | |
| (732) 736-1000 | |
| (732) 736-8811 |
| Full Name | Dr Leslie Catherine Taguba-madrid |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 1163 Route 37 W, Toms River, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801885389 | NPI | - | NPPES |
| 34156600 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 25MA09207900 (New Jersey) | Primary |
| Entity Name | Oscar T Ortiz Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336311125 PECOS PAC ID: 2668447285 Enrollment ID: O20040827000660 |
News Archive
In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as POTS.
A Hong Kong laboratory officially recognized by the World Health Organisation (WHO) has confirmed the latest four cases of bird flu infection in humans in Indonesia.
Gov. Rod R. Blagojevich today announced the launch of a $450,000 Web-based system that provides the state with up-to-the-minute information from more than 200 hospitals in Illinois on the availability of beds and other critical health care services necessary to guide the response to an act of terrorism or other public health emergency.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.
The Institute for Health Technology Studies (InHealth) has awarded three new research grants totaling more than $1.4 million to investigators at the University of Southern California, Northwestern University, and Stanford University. The funding will support three separate studies that will examine the social and economic impact of therapeutic medical devices, as well as the device innovation process.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leslie Catherine Taguba-madrid, MD 1163 Route 37 W, Suite A-1, Toms River, NJ 08755-4973 Ph: (732) 736-1000 | Dr Leslie Catherine Taguba-madrid, MD 1163 Route 37 W, Suite A-1, Toms River, NJ 08755-4973 Ph: (732) 736-1000 |
News Archive
In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as POTS.
A Hong Kong laboratory officially recognized by the World Health Organisation (WHO) has confirmed the latest four cases of bird flu infection in humans in Indonesia.
Gov. Rod R. Blagojevich today announced the launch of a $450,000 Web-based system that provides the state with up-to-the-minute information from more than 200 hospitals in Illinois on the availability of beds and other critical health care services necessary to guide the response to an act of terrorism or other public health emergency.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.
The Institute for Health Technology Studies (InHealth) has awarded three new research grants totaling more than $1.4 million to investigators at the University of Southern California, Northwestern University, and Stanford University. The funding will support three separate studies that will examine the social and economic impact of therapeutic medical devices, as well as the device innovation process.
› Verified 1 days ago
Dr. Vanie S Ramachandra Rao, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 14 Hospital Dr, Toms River, NJ 08755 Phone: 732-244-3100 | |
Dr. Gregory J Cuozzo, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 102 Commons Way, Toms River, NJ 08755 Phone: 732-349-4434 Fax: 732-349-9290 | |
Dr. Prabhat Kumar Sinha, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 20 Hospital Dr, Ste 3, Toms River, NJ 08755 Phone: 732-341-9900 Fax: 732-341-9968 | |
Dr. Satish K Bhutani, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1416 Hooper Ave, Toms River, NJ 08753 Phone: 848-223-7120 Fax: 732-349-6919 | |
Rajat K Dhar, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 442d Commons Way, Toms River, NJ 08755 Phone: 732-505-3510 Fax: 732-505-5308 | |
Dr. Joseph Anthony Decorso Jr., MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 20 Montreal Ct, Toms River, NJ 08757 Phone: 973-699-1830 | |
Dr. Martin Zaratan Jimenez, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 25 Mule Rd, Building A, Toms River, NJ 08755 Phone: 732-240-0404 Fax: 732-244-3555 |